EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS182-10637 
Organism
Homo sapiens 
Tissue/cell
Spleen 
Coordinate
chr19:907000-907970 
TF binding sites/motifs
Number: 7             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
KLF16MA0741.1chr19:907449-907460GGGGGCGGGGC-6.02
KLF5MA0599.1chr19:907450-907460GGGGCGGGGC-6.02
Nr2f6(var.2)MA0728.1chr19:907033-907048TGAACTCCTGACCTT-6.04
PLAG1MA0163.1chr19:907354-907368CCCCCTGAGGCCCC-6.02
SP4MA0685.1chr19:907446-907463AGAGGGGGCGGGGCTCG-6.24
SREBF2MA0596.1chr19:907500-907510ATCACCCCAT-6.02
ZfxMA0146.2chr19:907954-907968GAGGCCGAGGCGGG-6.01
Number of super-enhancer constituents: 1             
IDCoordinateTissue/cell
SE_10779chr19:905539-911000CD19_Primary
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr19907464907615
Number: 1             
IDChromosomeStartEnd
GH19I000906chr19906185910931
Enhancer Sequence
AGACGGGGTT TCACCATGTT GGCAGGCTGG TCTTGAACTC CTGACCTTAA GTGATCCGCC 60
TGCCTCAGCC TCCCAAAGTG CTGGGATTAC AGGCATGAGC TACCACGCCC GGCCCTCATT 120
ATACAGATTT GTAAACCAAG GCACAAAGTC ACCGCCCAAG CTCCCATTGC TGCAAAGAGG 180
GCAGCTGGAG AAGGAGGTGG TGGACCATGC CCTCAGCACA GAGCACAGCA GCCGACGGGT 240
ACTCAGTGGG AATACAGGGT CATGTTAAGC CAGCGTCTCT GAAGCTGGAT CAGCCTGAAG 300
CTGCCTCCCT GAGGCCGGAG CACTCTGTCC CATGCCCCAG ATTCACCCAC AGCCCCCCCT 360
GAGGCCCCGG GGCCTACTTC TCCACCCCAG CAGCTGGACA GGGCCGATAA CAGAAGTGAC 420
ATCCGAGGGG AGCCCTCGGG GAAGTCAGAG GGGGCGGGGC TCGGTGACAC AGCTCAAGCC 480
CTCCCAGCAA GGGGCCTGGT ATCACCCCAT ATTACAGATG AAGGATCTGA GGCTTGGAGA 540
GGTGGGGCTG TCCCCCGTCA CCACCCAGAC AATGCAAGGA GCTGGATGTG AACCTGGGTC 600
TGACCCAGAA CCCCAGAGCT ACCCTGCTTC CCTCACCACC CCTCATACCA AAGCCCCACA 660
GGCCTCTCCT CCAGGCCCAC AAGGACCTGC CTGGTCCTTC CCCTGCTCCA GCACAGCCCA 720
TGGCTCCCCA GCATCCCAGG GCCAGGCCTG GCTCCCCCTT GGCCTAGCAC TGCAACACGA 780
GGGCTTTCGC CTGTTTTGTT TGGTATCTGA GGGCTCGCCA CCCTCCCCTG GGTCTCTAGT 840
GCTGAGCTGA GCACTGGAAA TCGAGTCCCA CCATCAGATG GAGCTGGCTG ACTTCAACCA 900
GTTTCCAGCA GGAAATTAAG AAACATCTTC AAGCTTGTCA TCCCAGCACT TTGGGAGGCC 960
GAGGCGGGCG 970